C07K 14/4716
Muscle proteins
Official title: {Muscle proteins, e.g. myosin, actin}
C07K14/4716 (Muscle proteins) appears on 266 US grants and 378 published applications in this corpus.
Search patents in C07K- Granted patents
- 266
- Published applications
- 378
- Assignees
- 245
- Inventors
- 912
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1993 | 2 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 5 | 0 |
| 1997 | 6 | 0 |
| 1998 | 17 | 0 |
| 1999 | 8 | 0 |
| 2000 | 14 | 0 |
| 2001 | 11 | 2 |
| 2002 | 14 | 20 |
| 2003 | 7 | 22 |
| 2004 | 6 | 16 |
| 2005 | 6 | 15 |
| 2006 | 7 | 12 |
| 2007 | 10 | 10 |
| 2008 | 10 | 10 |
| 2009 | 9 | 10 |
| 2010 | 2 | 9 |
| 2011 | 7 | 8 |
| 2012 | 5 | 10 |
| 2013 | 3 | 7 |
| 2014 | 6 | 13 |
| 2015 | 10 | 10 |
| 2016 | 10 | 13 |
| 2017 | 11 | 14 |
| 2018 | 7 | 11 |
| 2019 | 11 | 21 |
| 2020 | 2 | 6 |
| 2021 | 7 | 19 |
| 2022 | 10 | 22 |
| 2023 | 7 | 19 |
| 2024 | 7 | 28 |
| 2025 | 20 | 28 |
| 2026 | 8 | 23 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Gene-therapy vectors for treating cardiomyopathy29 Sep 2026US 12,747,453 B2
- Gene-therapy vectors for treating cardiomyopathy22 Sep 2026US 12,742,181 B2
- Methods and compositions for increasing transduction efficiency with cell membrane fusion proteins26 May 2026US 12,636,380 B2Texas Tech University System
- Compositions and methods for modulating myosin subfragment-2 coiled coil stability and methods for using them5 May 2026US 12,617,818 B2University of North Texas
- Engineered muscle targeting compositions5 May 2026US 12,618,082 B2Massachusetts Institute of Technology
- Adeno-associated virus vector delivery of b-sarcoglycan and microrna-29 and the treatment of muscular dystrophy8 Oct 2026US 2026/0308212 A1Research Institute At Nationwide Children's Hospital
- Compositions and methods for recombinant aav production8 Oct 2026US 2026/0308620 A1REGENXBIO Inc.
- Engineered muscle targeting compositions27 Aug 2026US 2026/0250713 A1Massachusetts Institute of Technology
- Adeno-associated virus vector delivery of muscle specific micro-dystrophin to treat muscular dystrophy6 Aug 2026US 2026/0224751 A1Research Institute At Nationwide Children's Hospital
- Protein complex and production process thereof6 Aug 2026US 2026/0226418 A1Darwin Biotechnology (Hubei) Co., Ltd.
Most cited
By later US patents
- Modified proteins comprising controllable intervening protein sequences or their elements methods of producing same and methods for purification of a target protein comprised by a modified protein139US 5,834,247 ANew England Biolabs, Inc. · 1998
- Modification of protein by use of a controllable interveining protein sequence95US 5,496,714 ANew England Biolabs, Inc. · 1996
- Method for modulating smooth muscle cell proliferation95US 6,114,311 AArch Development Corporation · 2000
- Method for modulating smooth muscle cell proliferation93US 6,284,743 B1Arch Development Corporation · 2001
- Non-human mammal having a graft and methods of delivering protein to myocardial tissue84US 5,602,301 AIndiana University Foundation · 1997